SOPHiA GENETICS Partners With Precision for Medicine

MT Newswires Live2025-04-08

SOPHiA GENETICS (SOPH) partnered with Precision for Medicine to enhance biomarker discovery and precision medicine services, Precision for Medicine said Tuesday.

The company said it will integrate SOPHiA's DDM Platform for biomarker discovery, clinical trial assays, and advanced algorithms to expand its clinical trial capabilities.

The partnership will enable biopharma companies to accelerate clinical trial design, patient stratification, and data analysis through AI-driven algorithms that analyze complex multimodal data, including genomic, radiomic, and clinical data, the company said.

Additionally, the company said the MSK-ACCESS liquid biopsy test powered by SOPHiA DDM, supported by AstraZeneca (AZN), will be available as a service for biopharma clients.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2525855479?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-08 15:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2525855479","market":"hk","top_or_hot":-1,"title":"SOPHiA GENETICS Partners With Precision for Medicine","media":"MT Newswires Live","content":"<html><body><p> SOPHiA GENETICS (SOPH) partnered with Precision for Medicine to enhance biomarker discovery and precision medicine services, Precision for Medicine said Tuesday.</p><p>The company said it will integrate SOPHiA's DDM Platform for biomarker discovery, clinical trial assays, and advanced algorithms to expand its clinical trial capabilities.</p><p>The partnership will enable biopharma companies to accelerate clinical trial design, patient stratification, and data analysis through AI-driven algorithms that analyze complex multimodal data, including genomic, radiomic, and clinical data, the company said.</p><p>Additionally, the company said the MSK-ACCESS liquid biopsy test powered by SOPHiA DDM, supported by AstraZeneca (AZN), will be available as a service for biopharma clients.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SOPHiA GENETICS Partners With Precision for Medicine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSOPHiA GENETICS Partners With Precision for Medicine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-08 15:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> SOPHiA GENETICS (SOPH) partnered with Precision for Medicine to enhance biomarker discovery and precision medicine services, Precision for Medicine said Tuesday.</p><p>The company said it will integrate SOPHiA's DDM Platform for biomarker discovery, clinical trial assays, and advanced algorithms to expand its clinical trial capabilities.</p><p>The partnership will enable biopharma companies to accelerate clinical trial design, patient stratification, and data analysis through AI-driven algorithms that analyze complex multimodal data, including genomic, radiomic, and clinical data, the company said.</p><p>Additionally, the company said the MSK-ACCESS liquid biopsy test powered by SOPHiA DDM, supported by AstraZeneca (AZN), will be available as a service for biopharma clients.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2417539215.USD","symbol_name":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2525855479","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2525855479","pubTimestamp":1744099082,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"SOPHiA GENETICS  partnered with Precision for Medicine to enhance biomarker discovery and precision medicine services, Precision for Medicine said Tuesday.The company said it will integrate SOPHiA's DDM Platform for biomarker discovery, clinical trial assays, and advanced algorithms to expand its clinical trial capabilities.The partnership will enable biopharma companies to accelerate clinical trial design, patient stratification, and data analysis through AI-driven algorithms that analyze complex multimodal data, including genomic, radiomic, and clinical data, the company said.Additionally, the company said the MSK-ACCESS liquid biopsy test powered by SOPHiA DDM, supported by AstraZeneca , will be available as a service for biopharma clients.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","BK4588":"碎股","SOPH":"SOPHiA GENETICS SA","BK4568":"美国抗疫概念","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4539":"次新股","BK4585":"ETF&股票定投概念","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","BK4167":"医疗保健技术","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4007":"制药","AZN":"阿斯利康"},"translate_title":"SOPHiA GENETICS与Precision for Medicine合作","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SOPH":0.9,"AZN":0.9},"content_text":"SOPHiA GENETICS (SOPH) partnered with Precision for Medicine to enhance biomarker discovery and precision medicine services, Precision for Medicine said Tuesday.The company said it will integrate SOPHiA's DDM Platform for biomarker discovery, clinical trial assays, and advanced algorithms to expand its clinical trial capabilities.The partnership will enable biopharma companies to accelerate clinical trial design, patient stratification, and data analysis through AI-driven algorithms that analyze complex multimodal data, including genomic, radiomic, and clinical data, the company said.Additionally, the company said the MSK-ACCESS liquid biopsy test powered by SOPHiA DDM, supported by AstraZeneca (AZN), will be available as a service for biopharma clients.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2525855479","isCrawlerRequest":true}